Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (281-290 of 385) with videos related to

Pageof 39
Sort By:
Blood|October 28, 2018
Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammationSebastien Jacquelin, Jasmin Straube, Leanne Cooper, et al.
Blood Cancer Discovery|September 5, 2024
Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA MutationsLivius Penter, Nicoletta Cieri, Katie Maurer, et al.
Nature|July 2, 2015
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDSJan Krönke, Emma C Fink, Paul W Hollenbach, et al.
International Journal of Cancer|April 29, 2022
The landscape of genetic aberrations in myxofibrosarcomaYasuhide Takeuchi, Kenichi Yoshida, Adriane Halik, et al.
Blood|January 12, 2012
High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterationsMichael W M Kühn, Ina Radtke, Lars Bullinger, et al.
Blood Advances|December 22, 2020
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implicationNikolaus Jahn, Tobias Terzer, Eric Sträng, et al.
Leukemia|March 2, 2018
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesisChristopher Maximilian Arends, Joel Galan-Sousa, Kaja Hoyer, et al.
Blood|October 2, 2014
Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantationRichard F Schlenk, Sabine Kayser, Lars Bullinger, et al.
European Journal of Heart Failure|August 26, 2025
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trialMarkus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
Transfusion|July 29, 2025
Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cellsVladan Vučinić, Theresa Tumewu, Mandy Brückner, et al.
Pageof 39

Showing results (281-290 of 385) with videos related to

Sort By:
Pageof 39
Blood|October 28, 2018
Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammationSebastien Jacquelin, Jasmin Straube, Leanne Cooper, et al.
Blood Cancer Discovery|September 5, 2024
Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA MutationsLivius Penter, Nicoletta Cieri, Katie Maurer, et al.
Nature|July 2, 2015
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDSJan Krönke, Emma C Fink, Paul W Hollenbach, et al.
International Journal of Cancer|April 29, 2022
The landscape of genetic aberrations in myxofibrosarcomaYasuhide Takeuchi, Kenichi Yoshida, Adriane Halik, et al.
Blood|January 12, 2012
High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterationsMichael W M Kühn, Ina Radtke, Lars Bullinger, et al.
Blood Advances|December 22, 2020
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implicationNikolaus Jahn, Tobias Terzer, Eric Sträng, et al.
Leukemia|March 2, 2018
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesisChristopher Maximilian Arends, Joel Galan-Sousa, Kaja Hoyer, et al.
Blood|October 2, 2014
Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantationRichard F Schlenk, Sabine Kayser, Lars Bullinger, et al.
European Journal of Heart Failure|August 26, 2025
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trialMarkus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
Transfusion|July 29, 2025
Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cellsVladan Vučinić, Theresa Tumewu, Mandy Brückner, et al.
Pageof 39